Isabel Echavarría

Pathological Response in a Triple-Negative Breast Cancer Cohort Treated with Neoadjuvant Carboplatin and Docetaxel According to Lehmann's Refined Classification

Isabel Echavarría, Sara López‐Tarruella, Antoni C. Picornell et al. · Clinical Cancer Research · 2018 · 107 citations

Breast Oncology, Reliable Predictors, Medicine +15

Surgery for metastases for esophageal-gastric cancer in the real world: Data from the AGAMENON national registry

Alberto Carmona‐Bayonas, Paula Jiménez‐Fonseca, Isabel Echavarría et al. · European Journal of Surgical Oncology · 2018 · 59 citations

Surgical Oncology, Esophagus, Esophageal Cancer +11

Breast cancer PAM50 signature: correlation and concordance between RNA-Seq and digital multiplexed gene expression technologies in a triple negative breast cancer series

Antoni C. Picornell, Isabel Echavarría, Enrique L. Álvarez et al. · BMC Genomics · 2019 · 57 citations · Full text

Association of HER2DX with pathological complete response and survival outcomes in HER2-positive breast cancer

Guillermo Villacampa, Nadine Tung, Sònia Pernas et al. · Annals of Oncology · 2023 · 47 citations · Full text

Survival Outcomes, Breast Oncology, Medicine +9

Activity of docetaxel, carboplatin, and doxorubicin in patient-derived triple-negative breast cancer xenografts

Miguel Martín, Rocío Ramos‐Medina, Rebeca Bernat et al. · Scientific Reports · 2021 · 30 citations · Full text